FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or inhalation. A nasal COVID-19 vaccine, developed using technology from Washington University in St. Louis, is set to begin a Phase 1 clinical trial in the U.S. following FDA approval of an investigational new drug application submitted by [...]

from SciTechDaily https://ift.tt/7jgGOcE